Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: Ex-vivo and in-vivo investigations

BJU International

Volumn 103, Issue 6, 2009, Pages 770-775

  Seitz, Michael ^a   Bayer, Thomas ^b   Ruszat, Robin ^c   Tilki, Derya ^a   Bachmann, Alexander ^c   Gratzke, Christian ^a   Schlenker, Boris ^a   Stief, Christian ^a   Sroka, Ronald ^a   Reich, Oliver ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Kempten Hospital   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

BPH; Diode laser; Potassium titanyl phosphate; Prostate; TURP

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER NECK STENOSIS; BLOOD CLOTTING; CONTROLLED STUDY; DIODE LASER; EVALUATION; EX VIVO STUDY; HEMOSTASIS; HISTOLOGY; IN VIVO STUDY; KIDNEY; MALE; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; SWINE; TISSUE; TRANSURETHRAL RESECTION; VAPORIZATION;

ANIMALS; DOGS; FEASIBILITY STUDIES; KIDNEY; LASERS, SEMICONDUCTOR; MALE; PROSTATE; PROSTATIC HYPERPLASIA; SWINE; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 61349138258     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08066.x     Document Type: Article

References (26)

1. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate 1990 3 (Suppl. 61 74
2. Committee APG. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003 170 : 530 47
3. Costello AJ, Bowsher WG, Bolton DM, Braslis KG, Burt J. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol 1992 69 : 603 8
4. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998 51 : 254 6
5. Te AE, Malloy TR, Stein BS et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month Results from the first United States multicenter prospective trial. J Urol 2004 172 : 1404 8
6. Seitz M, Sroka R, Gratzke C et al. The diode laser: a novel side-firing approach for laser vaporisation of the human prostate - immediate efficacy and 1-year follow-up. Eur Urol 2007 52 : 1717 22
7. Seitz M, Ackermann A, Gratzke C et al. [Diode laser. Ex vivo studies on vaporization and coagulation characteristics]. Urologe A 2007 46 : 1242 7
8. Wendt-Nordahl G, Huckele S, Honeck P et al. 980-nm diode laser. A novel laser technology for vaporization of the prostate. Eur Urol 2007 52 : 1723 8
9. Kohrmann KU, Back W, Bensemann J et al. The isolated perfused kidney of the pig: new model to evaluate shock wave-induced lesions. J Endourol 1994 8 : 105 10
10. Michel MS, Kohrmann KU, Weber A, Krautschick AW, Alken P. Rotoresect. new technique for resection of the prostate: experimental phase. J Endourol 1996 10 : 473 8
11. Peters K, Michel MS, Matis U, Hocker A. [The isolated perfused porcine kidney model for investigations concerning surgical therapy procedures]. ALTEX 2006 23 : 203 7
12. Reich O, Schneede P, Corvin S, Zaak D, Sroka R, Hofstetter A. Combination of interstitial laser coagulation and transurethral resection of the prostate: ex vivo evaluations. Urology 2003 61 : 1172 6
13. Reich O, Corvin S, Oberneder R, Sroka R, Muschter R, Hofstetter A. In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP). Urol Res 2002 30 : 15 20
14. Doerr W. [Use of triphenyltetrazolium chloride as a reduction indicator in histology and histophysiology]. Frankf Z Pathol 1950 61 : 557 73
15. Kaplan SA. AUA Guidelines and their impact on the management of BPH. An update. Rev Urol 2004 6 (Suppl. 9 S46 52
16. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol 2004 46 : 547 54
17. Reich O, Seitz M, Gratzke C, Schlenker B, Bachmann A, Stief C. [Benign prostatic syndrome (BPS). Ablative treatments]. Urologe A 2006 45 : 769 80 quiz 81 2
18. Gilling PJ, Fraundorfer MR. Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 1998 8 : 11 5
19. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997 49 : 703 8
20. 2-laser. Med Laser Appl 2002 17 : 190 200
21. Seitz M, Reich O, Gratzke C et al. High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates. Lasers Med Sci 2008 Epub ahead of print
22. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004 171 : 2502 4
23. Cooper TE, Trezek GJ. A probe technique for determining the thermal conductivity of tissue. J Heat Transfer 1972 94 : 133
24. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl- phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 1996 48 : 575 83
25. Hermanns T, Sulser T, Fatzer M et al. Laser fibre deterioration and loss of power output during photo-selective 80-W potassium-titanyl-phosphate laser vaporisation of the prostate. Eur Urol 2008 Epub ahead of print
26. Montorsi F, Naspro R, Salonia A et al. Holmium laser enucleation versus transurethral resection of the prostate: Results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2008 179 : S87 90